India’s Biocon Biologics has launched a new outreach initiative in diabetes, together with Asia’s largest research and professional organization for the therapy 15 November 2021
Japanese drugmaker Daiichi Sankyo has launched a biosimilar product in its home country referencing the Roche cancer drug Avastin (bevacizumab). 19 December 2019
Samsung Bioepis has announced that the US Food and Drug Administration has accepted for review the its Biologics License Application (BLA) under the 351(k) path 19 November 2019
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.